A randomized crossover study of single biweekly administration of epoetin-α compared with darbepoetin-α in chronic kidney disease patients not receiving dialysis.

about

A randomized crossover study of single biweekly administration of epoetin-α compared with darbepoetin-α in chronic kidney disease patients not receiving dialysis.

Item

http://www.wikidata.org/entity/Q41988313

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

A randomized crossover study o ...... tients not receiving dialysis.

@en

type

Item

label

A randomized crossover study o ...... tients not receiving dialysis.

@en

prefLabel

A randomized crossover study o ...... tients not receiving dialysis.

@en

P1476

A randomized crossover study o ...... tients not receiving dialysis.

@en

P2093

Dong-Ho Yang

http://www.w3.org/2001/XMLSchema#string

Ha-Young Na

http://www.w3.org/2001/XMLSchema#string

Jong-Ho Lee

http://www.w3.org/2001/XMLSchema#string

Jong-Oh Song

http://www.w3.org/2001/XMLSchema#string

Jung-Hwan Park

http://www.w3.org/2001/XMLSchema#string

Sug-Kyun Shin

http://www.w3.org/2001/XMLSchema#string

Woong Cheon

http://www.w3.org/2001/XMLSchema#string

Yong-Kyu Lee

http://www.w3.org/2001/XMLSchema#string

Young-Il Jo

http://www.w3.org/2001/XMLSchema#string

P2860

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

Extended dosing intervals with erythropoiesis-stimulating agents in chronic kidney disease: a review of clinical data.

Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients.

A randomized controlled study comparing once-weekly to every-2-week and every-4-week dosing of epoetin alfa in CKD patients with anemia.

Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes.

Low-Dose Treatment with Erythropoiesis-Stimulating Agents and Cardiovascular Geometry in Chronic Kidney Disease: Is Darbepoetin-α More Effective than Expected?

A randomized study of extended dosing regimens for initiation of epoetin alfa treatment for anemia of chronic kidney disease.

Pharmacokinetic and pharmacodynamic profiles of extended dosing of epoetin alfa in anemic patients who have chronic kidney disease and are not on dialysis.

Use of darbepoetin alfa in the treatment of anaemia of chronic kidney disease: clinical and pharmacoeconomic considerations.

Association of anemia and erythropoiesis stimulating agents with inflammatory biomarkers in chronic kidney disease

P304

210-216

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.KRCP.2014.10.001

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275244404

http://www.w3.org/2001/XMLSchema#string

P698

26885479

http://www.w3.org/2001/XMLSchema#string

P921

renal dialysis

Darbepoetin alfa

P932

4714283

http://www.w3.org/2001/XMLSchema#string